10 employees
RhinoCyte develops and commercializes diagnostic tools and therapies for the stem cell treatment of neurological diseases.
2005
$930K
from 2 investors over 2 rounds
RhinoCyte, Inc. raised $930K on August 7, 2006
Investors: Keyhorse Capital and Queen City Angels